A pilot randomized study of ranolazine for reduction of myocardial damage during elective percutaneous coronary intervention

F Pelliccia, V Pasceri, G Marazzi, G Rosano… - American Heart …, 2012 - Elsevier
BACKGROUND: Ranolazine is a new antianginal drug that reduces intracellular sodium and
calcium accumulation during ischemia, thus potentially limiting myocardial ischemia. It …
被引用次数：47 相关文章

A pilot randomized study of ranolazine for reduction of myocardial damage during elective percutaneous coronary intervention.

F Pelliccia, V Pasceri, G Marazzi, G Rosano… - American Heart …, 2012 - europepmc.org
Background Ranolazine is a new antianginal drug that reduces intracellular sodium and
calcium accumulation during ischemia, thus potentially limiting myocardial ischemia. It …

A pilot randomized study of ranolazine for reduction of myocardial damage during elective percutaneous coronary intervention

F Pelliccia, V Pasceri, G Marazzi, G Rosano… - American Heart …, 2012 - infona.pl
Ranolazine is a new antianginal drug that reduces intracellular sodium and calcium
accumulation during ischemia, thus potentially limiting myocardial ischemia. It remains …

[引用][C] A pilot randomized study of ranolazine for reduction of myocardial damage during elective percutaneous coronary intervention

F PELLICCIA, V PASCERI, G MARAZZI… - The American heart …, 2012 - pascal-francis.inist.fr
A pilot randomized study of ranolazine for reduction of myocardial damage during elective
percutaneous coronary intervention CNRS Inist Pascal-Francis CNRS Pascal and Francis …

A pilot randomized study of ranolazine for reduction of myocardial damage during elective percutaneous coronary intervention

F Pelliccia, V Pasceri, G Marazzi, G Rosano, C Greco… - 2012 - pubmed.ncbi.nlm.nih.gov
Background Ranolazine is a new antianginal drug that reduces intracellular sodium and
calcium accumulation during ischemia, thus potentially limiting myocardial ischemia. It …

A pilot randomized study of ranolazine for reduction of myocardial damage during elective percutaneous coronary intervention

F Pelliccia, V Pasceri, G Marazzi, G Rosano… - AMERICAN HEART …, 2012 - iris.uniroma1.it
Background: Ranolazine is a new antianginal drug that reduces intracellular sodium and
calcium accumulation during ischemia, thus potentially limiting myocardial ischemia. It …

A pilot randomized study of ranolazine for reduction of myocardial damage during elective percutaneous coronary intervention

F Pelliccia, V Pasceri, G Marazzi, G Rosano… - AMERICAN HEART …, 2012 - iris.uniroma1.it
Background: Ranolazine is a new antianginal drug that reduces intracellular sodium and
calcium accumulation during ischemia, thus potentially limiting myocardial ischemia. It …

[引用][C] A pilot randomized study of ranolazine for reduction of myocardial damage during elective percutaneous coronary intervention

F PELLICCIA, V PASCERI, G MARAZZI… - The American heart …, 2012 - Mosby

[引用][C] A pilot randomized study of ranolazine for reduction of myocardial damage during elective percutaneous coronary intervention

F Pelliccia, V Pasceri, G Marazzi… - The American Heart …, 2012 - Elsevier Limited